Shanghai Junshi Biosciences (HKG:1877 investor three-year losses grow to 77% as the stock sheds HK$1.2b this past week

Date:

As every investor would know, not every swing hits the sweet spot. But you have a problem if you face massive losses more than once in a while. So consider, for a moment, the misfortune of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) investors who have held the stock for three years as it declined a whopping 77%. That’d be enough to cause even the strongest minds some disquiet. And over the last year the share price fell 53%, so we doubt many shareholders are delighted. On top of that, the share price is down 9.1% in the last week.

With the stock having lost 9.1% in the past week, it’s worth taking a look at business performance and seeing if there’s any red flags.

View our latest analysis for Shanghai Junshi Biosciences

Shanghai Junshi Biosciences wasn’t profitable in the last twelve months, it is unlikely we’ll see a strong correlation between its share price and its earnings per share (EPS). Arguably…

Read more…

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Tampa RV giant Lazydays to delist from Nasdaq

Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...

Granite Geek: New Hampshire might get access to ‘balcony solar’

I had solar panels put on my roof six...

TSX Today: What to Watch for in Stocks on Monday, November 10

Despite firm gold and silver prices, Canadian stocks...

While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!

As market-wide fear grips the sector, the Binance Coin...